Viewing nowKavalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 201109254 · Approved 2011.10.27 · Insurance code 665001550
Treatment of peripheral and central neuropathic pain, adjunctive effect for partial seizures, improvement of fibromyalgia
This medication is used to relieve peripheral and central neuropathic pain in adults. It is also administered as an adjunct to help control symptoms in adults who experience partial seizures. Additionally, it is used to treat fibromyalgia, reducing pain and discomfort. In summary, this drug is utilized in the treatment of neuropathic pain, partial seizures, and fibromyalgia.
This medication should be taken orally in divided doses totaling 1 daily dose, without regard to food. 1. Neuropathic Pain - Peripheral Neuropathic Pain: An initial dose of 150 mg can be taken daily, and after 3 to 7 days, it can be increased to a daily dose of 300 mg; if needed, it can be further increased to a maximum of 600 mg daily at 7-day intervals. - Central Neuropathic Pain: Starting dosage is 150 mg daily, available for adjustment.
This medication acts on the nervous system and is used to treat various neuropathic pain and epilepsy. During treatment, there is a risk of changes in mental health, such as suicidal thoughts or behaviors, and depression, so patients and guardians should carefully monitor for these changes. Patients with allergies to any ingredient in this medication or those with specific genetic lactose intolerance should not take it. Diabetic patients may experience weight gain from this medication, which may necessitate adjustments in blood sugar control medications. If symptoms of hypersensitivity such as swelling of the face or around the mouth occur, the medication should be discontinued immediately. Older adults may experience dizziness or drowsiness, increasing the risk of falls, so caution is necessary, and they should avoid driving or operating dangerous machinery until they are accustomed to the effects of the medication. This medication may cause temporary blurred vision or changes in vision, and if there are any abnormal symptoms, consultation with medical personnel is advised. Sudden discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so it should be tapered off gradually under a doctor's guidance. Due to the risk of drug abuse, patients with a history of mental disorders or drug abuse should exercise special caution. Patients with heart or kidney diseases must consult with medical personnel before taking this medication, as there is a risk of severe respiratory depression in those with respiratory or central nervous system diseases, necessitating dosage adjustments. In early pregnancy, there is a risk of fetal malformations, so women who are pregnant or planning to become pregnant must consult with a doctor and use effective contraceptive methods. Nursing mothers should consult with medical personnel regarding whether to discontinue breastfeeding or the medication, as it can be transmitted through breast milk. This medication is primarily excreted unchanged in urine, making the potential for interactions with other drugs low; however, caution is warranted when taken with alcohol or central nervous system depressants, as there is an increased risk of drowsiness and respiratory depression. In cases of overdose, confusion, drowsiness, depression, seizures, etc., may occur; immediate emergency treatment is required. This medication should be kept out of the reach of children and not transferred to other containers for safety. If severe rashes, swelling, or breathing difficulties occur during use, the medication should be stopped immediately, and medical facilities should be visited. This medication can cause dizziness and drowsiness, so it is advisable to avoid driving or operating dangerous machinery after taking it.
Hives, severe swelling (including angioedema, facial swelling, swelling around the mouth and upper airway), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reactions (including Stevens-Johnson syndrome, toxic epidermal necrolysis), difficulty breathing or respiratory distress, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes,
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain the storage temperature between 15 and 30 degrees Celsius to preserve the drug's effectiveness.
This medication is a hard capsule with a white upper part and white lower part containing a white powder.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.